176 related articles for article (PubMed ID: 30985961)
1. The prevalence of human T-cell leukemia virus in blood donors in China.
Li L; Ou S; Huang C; Zhou X; Ge H; Li J; Zeng J; Zhou A; He L; Xu Q; Wu J; Li L; Wang C; Zang L; Huang L; Niu L; Han H; Zhang G; Wan J; Wang F; Xu T; Zhao B; Qian L; Wu Y; Liu Z
Transfusion; 2019 Jul; 59(7):2361-2367. PubMed ID: 30985961
[TBL] [Abstract][Full Text] [Related]
2. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
3. HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China.
Zhao J; Zhao F; Han W; Xu X; Wang L; Li R; Li T; Wu L; Du D; Zeng X; Cui X; Chen Y; Zeng J; Wang L
BMC Infect Dis; 2020 Aug; 20(1):581. PubMed ID: 32762656
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of HTLV-1/2 Among Voluntary Blood Donors in Vietnam.
Pham D; Nguyen D; Nguyen TA; Tran C; Tran L; Devare S; Tran A; Bhatnagar S
AIDS Res Hum Retroviruses; 2019 Apr; 35(4):376-381. PubMed ID: 30565470
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria.
Durojaiye I; Akinbami A; Dosunmu A; Ajibola S; Adediran A; Uche E; Oshinaike O; Odesanya M; Dada A; Okunoye O
Pan Afr Med J; 2014; 17():301. PubMed ID: 25328597
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
Niazi SK; Bhatti FA; Salamat N
J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.
Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T
Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716
[TBL] [Abstract][Full Text] [Related]
8. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
10. Confirming the presence of HTLV-1 infection and the absence of HTLV-2 in blood donors from Arequipa, Peru.
Quispe NC; Feria EB; Santos-Fortuna Ede L; Caterino-de-Araujo A
Rev Inst Med Trop Sao Paulo; 2009; 51(1):25-9. PubMed ID: 19229387
[TBL] [Abstract][Full Text] [Related]
11. Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009.
Carneiro-Proietti AB; Sabino EC; Leão S; Salles NA; Loureiro P; Sarr M; Wright D; Busch M; Proietti FA; Murphy EL;
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1265-72. PubMed ID: 22324906
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
13. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
14. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
[TBL] [Abstract][Full Text] [Related]
16. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results.
Busch MP; Switzer WM; Murphy EL; Thomson R; Heneine W
Transfusion; 2000 Apr; 40(4):443-9. PubMed ID: 10773057
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.
Xie J; Ge S; Zhang Y; Lin Y; Ni H; Zhang J; Chen C
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656
[TBL] [Abstract][Full Text] [Related]
18. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
Fawaz NA; Tamim H; Almawi WY
Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
[TBL] [Abstract][Full Text] [Related]
19. Discordant human T-lymphotropic virus screening with Western blot confirmation: evaluation of the dual-test algorithm for US blood donations.
Stramer SL; Townsend RL; Foster GA; Johnson R; Weixlmann B; Dodd RY
Transfusion; 2018 Mar; 58(3):638-640. PubMed ID: 29322517
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.
Busch MP; Laycock M; Kleinman SH; Wages JW; Calabro M; Kaplan JE; Khabbaz RF; Hollingsworth CG
Blood; 1994 Feb; 83(4):1143-8. PubMed ID: 8111054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
